Common Cancer List

MB1 Common Cancers (2)

to view the slide as a whole, click here

	Age	Sex	Organ	Diagnosis	pTNM	Stage
1	66	F	breast	infiltrating duct carcinoma	T2N0M0	IIA	view at 20X	view at 40X
2	43	F	breast	infiltrating duct carcinoma	T3N1M0	IIIA	view at 20X	view at 40X
3	58	F	breast	infiltrating duct carcinoma	T2N1M0	IIIA	view at 20X	view at 40X
4	46	F	breast	infiltrating duct carcinoma	T3N1M0	IIIB	view at 20X	view at 40X
5	71	F	breast	infiltrating papillary carcinoma with signet ring cell	T3N1M0	IIIA	view at 20X	view at 40X
6	37	F	breast	infiltrating duct carcinoma	T3N1M0	IIIA	view at 20X	view at 40X
7	59	F	breast	mixed infiltrating duct and lobular carcinoma	T3N1M0	IIIA	view at 20X	view at 40X
8	30	F	breast	medullary carcinoma	T3N0M0	IIB	view at 20X	view at 40X
9	47	F	breast	atypical medullary carcinoma	T2N1M0	IIB	view at 20X	view at 40X
10	46	F	breast	infiltrating duct carcinoma	T3N1M0	IIIA	view at 20X	view at 40X
11	32	M	liver	combined hepatocellular and cholangiocarcinoma	T3N0M0	IIIA	view at 20X	view at 40X
12	57	M	liver	hepatocellular carcinoma	T3N0M0	IIIA	view at 20X	view at 40X
13	58	F	liver	hepatocellular carcinoma	T2N0M0	II	view at 20X	view at 40X
14	20	M	liver	hepatocellular carcinoma	T4N0M0	IVA	view at 20X	view at 40X
15	63	F	liver	hepatocellular carcinoma	T2N0M0	II	view at 20X	view at 40X
16	66	F	liver	hepatocellular carcinoma	T2N0M0	II	view at 20X	view at 40X
17	61	M	liver	hepatocellular carcinoma	T3N0M0	IIIA	view at 20X	view at 40X
18	52	M	liver	hepatocellular carcinoma	T3N0M0	IIIA	view at 20X	view at 40X
19	50	M	liver	combined hepatocellular and cholangiocarcinoma	T3N1M0	IIIB	view at 20X	view at 40X
20	56	M	liver	hepatocellular carcinoma	T3N0M0	IIIA	view at 20X	view at 40X
21	53	M	urinary	mucinous adenocarcinoma			view at 20X	view at 40X
22	60	M	urinary	transitional cell carcinoma	T3bN1M0	IV	view at 20X	view at 40X
23	72	M	urinary	transitional cell carcinoma	T3bN1M0	IV	view at 20X	view at 40X
24	65	M	urinary	transitional cell carcinoma	T4aN1M1	IV	view at 20X	view at 40X
25	74	M	urinary	papillary transitional cell carcinoma	T1N0M0	I	view at 20X	view at 40X
26	63	F	urinary	papillary transitional cell carcinoma	T1N0M0	I	view at 20X	view at 40X
27	58	M	urinary	transitional cell carcinoma	T3NxM0	III	view at 20X	view at 40X
28	46	M	urinary	papillary transitional cell carcinoma	T1N0M0	I	view at 20X	view at 40X
29	76	M	urinary	transitional cell carcinoma	T3NxM0	III	view at 20X	view at 40X
30	63	M	urinary	transitional cell carcinoma	T3bN0M0	III	view at 20X	view at 40X
31	57	F	ovary	papillary serous cystadeno-ca	T3bN1M0	IIIc	view at 20X	view at 40X
32	48	F	ovary	papillary serous cystadeno-ca, moderately	T3cN0M0	IIIc	view at 20X	view at 40X
33	60	F	ovary	papillary serous cystadeno-ca, poorly differentitated	T2cN0M0	IIc	view at 20X	view at 40X
34	41	F	ovary	papillary serous cystadeno-ca, moderately	T2cN1M0	IIIc	view at 20X	view at 40X
35	64	F	ovary	papillary serous cystadeno-ca	T3cN0M0	IIIc	view at 20X	view at 40X
36	60	F	ovary	papillary serous cystadeno-ca	T3cN1M0	IIIc	view at 20X	view at 40X
37	54	F	ovary	papillary serous cystadeno-ca	T3aN0M0	IIIa	view at 20X	view at 40X
38	58	F	ovary	papillary serous cystadeno-ca	T2cN0M0	IIc	view at 20X	view at 40X
39	16	F	ovary	mucinous cystadeno-ca	T1aN0M0	Ia	view at 20X	view at 40X
40	57	F	ovary	serous cystadeno-ca, poorly differentiated	T3cN0M0	IIIc	view at 20X	view at 40X
41	66	M	pancreas	ductal ad-ca, moderately differentiated	T4N1aM0	IVA	view at 20X	view at 40X
42	63	M	pancreas	ductal ad-ca, moderately differentiated	T3N0M0	II	view at 20X	view at 40X
43	62	M	pancreas	ductal ad-ca, moderately differentiated	T2N1bM0	III	view at 20X	view at 40X
44	45	M	pancreas	ductal ad-ca, moderately differentiated	T4N1aM0	IVA	view at 20X	view at 40X
45	64	F	pancreas	ductal ad-ca, moderately differentiated	T4N0M0	IVA	view at 20X	view at 40X
46	64	F	pancreas	ductal ad-ca, moderately differentiated	T2N1bM0	III	view at 20X	view at 40X
47	63	M	pancreas	ductal ad-ca, poorly differentiated	T4NxM0	IVA	view at 20X	view at 40X
48	46	M	pancreas	ductal ad-ca, moderately differentiated	T3N1bM0	III	view at 20X	view at 40X
49	54	M	pancreas	ductal ad-ca, moderately differentiated	T3N1bM0	III	view at 20X	view at 40X
50	40	M	pancreas	ductal ad-ca, moderately differentiated	T3N1bM0	III	view at 20X	view at 40X
51	85	M	prostate	adenocarcinoma	TxNxM1	IV	view at 20X	view at 40X
52	79	M	prostate	adenocarcinoma	T2aNxM1	IV	view at 20X	view at 40X
53	53	M	prostate	adenocarcinoma	T2aNxM1	IV	view at 20X	view at 40X
54	72	M	prostate	adenocarcinoma	TxNxM1 (D2)	IV	view at 20X	view at 40X
55	82	M	prostate	adenocarcinoma	T2N0M1	IV	view at 20X	view at 40X
56	76	M	prostate	adenocarcinoma	T3aN0M0	III	view at 20X	view at 40X
57	56	M	prostate	adenocarcinoma	T2N1M0	IV	view at 20X	view at 40X
58	66	M	prostate	adenocarcinoma	T4N0M0	IV	view at 20X	view at 40X
59	54	M	prostate	adenocarcinoma	T1aN0M0 (G2)	I	view at 20X	view at 40X
60				carbon			view at 20X	view at 40X